RBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)
In a report released on March 10, Charles Weston from RBC Capital maintained a Hold rating on Alliance Pharma (APH – Research Report), with a ...
Alliance Pharma Valued at $468 Million Under Increased Offer From Aegros Bidco
Alliance Pharma said it has accepted an increased cash offer from Aegros Bidco, which values the London-listed company at approximately 362 million pounds ($467.8 million). The medicine and healthcare ...